In a German study, researchers evaluated six months of therapy with Cernilton on men with chronic prostatitis or prostatodynia (prostate pain). Of 72 men with uncomplicated prostatitis, 56 (78 percent) had pavorable response, and 26 (36 percent) were cured of symptoms and signs. Thirty (42 percent) demonstrated improved urine flow rate and decreased immune and inflammatory signs in their ejaculate. (Note, however, that of 18 additional subjects who had complications, such as urethral stricture, prostatic calculi, and bladder neck sclerosis, only one responded to Cernilton therapy)

The researchers attribute these effects to the extract’s anti-inflammatory or antiandrogenic properties. More rigorous research is needed to ascertain the mechanism of flower pollen therapy for prostatitis.